Nasr Fariman Pharmaceutical Company
Nasr Fariman Pharmaceutical Company is a private Iranian manufacturer of sterile injectable veterinary medicines and related animal-health products. It operates a Fariman production facility, supported by offices in Mashhad and Tehran, and targets neighboring-country and Middle East exports. The company matters to veterinary distributors, livestock-sector buyers and partners seeking sterile injectable supply from Iran.
Operations & footprint
Products and services
Nasr Fariman Pharmaceutical Company manufactures sterile injectable veterinary medicines and related animal-health products, including injectable antibiotics, powdered and liquid antibiotics, vitamins, minerals, antiparasitic products, anti-allergic products, hormones, anti-inflammatory drugs, anesthetics, distilled water, and isotonic and hypertonic serum products. Its production base is linked to veterinary medicine, livestock productivity, sterile manufacturing, GMP compliance, and animal-health supply chains.
Operations and assets
The Fariman manufacturing facility covers more than 33,000 square metres and is designed to produce more than 100,000 units of sterile injectable drugs per day. Production operates under Iran Veterinary Organization supervision, with GMP-certified production lines and stated alignment with USP, BP and EP standards.
Geographic footprint
Manufacturing is based in Fariman, Razavi Khorasan Province, with offices in Mashhad and Tehran. The company targets export sales in neighboring countries and the Middle East.
Commercial and investment relevance
Nasr Fariman is relevant for investors assessing Iran's veterinary pharmaceutical market, sterile injectable capacity, animal-health supply chains, livestock productivity, food-security inputs, and export potential in regional veterinary medicine. It can support analysis of how animal disease management, veterinary regulation, imported active ingredients, and sterile-production technology affect agriculture-linked pharmaceutical demand. Due diligence should verify ownership, veterinary licenses, GMP status, product registrations, export destinations, API sourcing, sterile line capacity, cold-chain or distributor arrangements, energy and water reliability, and exposure to currency or sanctions-related supplier constraints. Nasr Fariman supplies veterinary medicines central to treatment, prevention and supportive care in livestock and animal-health channels. Its sterile injectable capability is particularly relevant to veterinary distributors, livestock-sector buyers, and suppliers of pharmaceutical inputs and packaging.
Constraints, risk & compliance
Key risks and constraints
Commercial performance depends on maintaining sterile-production quality, GMP-certified line operations and veterinary product compliance. The business also faces execution risk in converting its regional export focus into sustained market access and sales.
Need more than a public profile?
Ask Hormuz to investigate, verify or act locally around Nasr Fariman Pharmaceutical Company. Tell us exactly what you need.
Connected Intelligence
Relevant geography, industry, market and execution context for this profile.
Frequently asked questions
Direct answers to the questions most likely to arise when reviewing this profile.
What does Nasr Fariman Pharmaceutical Company manufacture?
The company manufactures sterile injectable veterinary medicines, powdered and liquid antibiotics, vitamins and minerals, antiparasitics, hormones, anesthetics, serum products and distilled water.
Where is Nasr Fariman Pharmaceutical Company located?
Its factory is located on the Torbat Jam Road in Fariman, Razavi Khorasan Province, with offices in Mashhad and Tehran.
What is Nasr Fariman’s sterile injectable production capacity?
The company states that its Fariman facility can produce more than 100,000 units of sterile injectable drugs per day.
Does Nasr Fariman export veterinary medicines?
The company targets exports to neighboring countries and the Middle East.